NUVEEN ASSET MANAGEMENT, LLC – Vertex Pharmaceuticals Incorporated Transaction History
NUVEEN ASSET MANAGEMENT, LLC portfolio value:
$386.49M
portfolio value
NUVEEN ASSET MANAGEMENT, LLC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +6.62% | 82.93K shares | 33.71M | $289.54 | 1.33M |
| Q2 2022 | share | Decrease | -0.46% | -5.83K shares | 38.01M | $281.79 | 1.25M |
| Q1 2022 | share | Decrease | -6.41% | -86.1K shares | 19.65M | $260.97 | 1.25M |
| Q4 2021 | share | Decrease | -1.57% | -21.39K shares | 47.46M | $222.45 | 1.34M |
| Q3 2021 | share | Decrease | -51.36% | -1.44M shares | -318.27M | $181.39 | 1.36M |
| Q2 2021 | share | Increase | +2.31% | 63.27K shares | -23.62M | $201.63 | 2.80M |
| Q1 2021 | share | Increase | +4.65% | 121.95K shares | -30.02M | $214.89 | 2.74M |
| Q4 2020 | share | Decrease | -25.14% | -880.51K shares | -333.40M | $236.34 | 2.62M |
| Q3 2020 | share | Increase | +0.68% | 23.57K shares | -56.85M | $272.12 | 3.50M |
| Q2 2020 | share | Increase | +26.41% | 726.72K shares | 355.05M | $290.31 | 3.47M |
| Q1 2020 | share | Increase | +9.49% | 238.59K shares | 104.52M | $237.95 | 2.75M |
| Q4 2019 | share | Increase | +21.57% | 445.82K shares | 200.00M | $218.95 | 2.51M |
| Q3 2019 | share | Decrease | -10.41% | -240.15K shares | -72.89M | $169.42 | 2.06M |
| Q2 2019 | share | Increase | +14936.84% | 2.29M shares | 420.30M | $183.38 | 2.30M |
| Q1 2019 | share | Decrease | -0.02% | -3 shares | 280K | $183.95 | 15.34K |
| Q4 2018 | share | Decrease | -0.70% | -108 shares | -436K | $165.71 | 15.34K |
| Q3 2018 | share | Decrease | -3.07% | -490 shares | 269K | $192.74 | 15.45K |
| Q2 2018 | share | Decrease | -12.96% | -2.37K shares | -276K | $169.96 | 15.94K |
| Q1 2018 | share | Decrease | -33.13% | -9.07K shares | -1.12M | $162.98 | 18.32K |
| Q4 2017 | share | Decrease | -69.06% | -61.13K shares | -9.35M | $149.86 | 27.39K |
| Q3 2017 | share | Decrease | -26.36% | -31.68K shares | -2.03M | $152.04 | 88.53K |
| Q2 2017 | share | Increase | +80.02% | 53.43K shares | 8.19M | $128.87 | 120.21K |
| Q1 2017 | share | Increase | +17.80% | 10.09K shares | 3.12M | $109.35 | 66.78K |
| Q4 2016 | share | Decrease | -68.90% | -125.60K shares | -11.72M | $73.67 | 56.68K |
| Q3 2016 | share | Increase | +15.64% | 24.65K shares | 2.33M | $87.21 | 182.29K |
| Q2 2016 | share | Increase | +890.38% | 141.72K shares | 12.29M | $86.02 | 157.63K |
| Q1 2016 | share | Decrease | -1.54% | -249 shares | -768K | $79.49 | 15.91K |